Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Marie Skłodowska-Curie Action · Running

LiverAid Perfusable 3D-Bioprinted Human Liver-on-a-Chip with Silk–dECM Bioink for Biopharmaceutics

Coordinator
Friedrich-Schiller-Universität Jena, Germany
Runs
1 September 2026 to 31 August 2028
Status
Running
EU funding
€218k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101280630

What the project is doing

In the project's own words, from its summary on CORDIS.

LiverAid aims to develop a next-generation bioengineered human liver-on-chip platform to improve the predictability of drug toxicity testing and disease modeling. This system integrates advanced 3D bioprinting with smart hydrogels, patient-derived liver cells, and perfusable microfluidics to more accurately replicate the human liver microenvironment. By combining biofabrication with embedded sensors and real-time readouts, LiverAid will allow continuous monitoring of key physiological and biochemical markers, such as albumin production, urea synthesis, cytochrome P450 activity, and inflammatory responses.

The platform will be validated against conventional 2D/3D models using known hepatotoxins and rescue agents. This project aligns with the EU’s goals for reducing animal testing and improving personalized medicine approaches. It will also provide the applicant with hands-on training in organ-on-chip engineering, biosensing, and ML-assisted data analysis at the host institution in Germany, further strengthening their academic career and European research integration.

Topics

Who is involved

OrganisationCityCountryRole
Friedrich-Schiller-Universität JenaJenaGermanyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI